This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast ...

Retesting biomarkers is crucial when cancer progression deviates from expected patterns. An expert discusses the next steps ...

Researchers at Baylor College of Medicine and Rice University have received a $2.3 million Breakthrough Award from the ...

"Before, there was that balance of 'what is time worth?' And now, that's taken that stress away somewhat." ...

Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.

On Nature published the results of an innovative breast cancer research project from the Netherlands. This study, the SONIA ...

Top Forbes | SHOOK financial advisors and Wall Street investment firms have pledged more than $500,000 toward development of ...

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the American Society of Hematology (ASH) Annual Meeting, Dec. 7-10 in San ...

Barbara O’Brien, MD, discusses the next steps of the phase 2 TBCRC049 study for the treatment of patients with HER2-positive ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...

Join clinical experts as they address treatment challenges for breast cancer patients & explore the latest advancements at ...